Chinese Journal of Dermatology

• Original articles • Previous Articles     Next Articles

Immunological changes in HIV-1-infected patients treated with highly active antiretroviral therapy

ZHENG Yu-huang, CHEN Jun, LEI Jian-hua, LAI Li-ying, ZHU Ying-hua, HE Yan, LUO Hong-yu, ZHOU Hua-ying, DING Pei-pei, ZHANG Chun-ying, LI Hui   

  1. Research Laboratory of AIDS, The Second Xiang-Ya Hospital, Central-South University, Changsha 410011, China
  • Received:2006-01-20 Online:2006-04-15 Published:2006-04-15

Abstract: Objective To study immunological changes in HIV-1 infected Chinese patients receiving highly active antiretroviral therapy (HARRT).Methods HIV-1 viral load (VL),numbers of CD3+CD4+,CD3+CD8+,CD4+CD45RA+CD62L+,CD4+CD45RO+,CD8+CD38+,CD4+CD28+,CD8+CD28+ T lymphocytes and plasma soluble CD27 (sCD27) were measured in 37 HIV-1-infected patients who were given three drug-regimens based on two nucleoside reverse transcriptase inhibitors (NRTIs) and an non-NRTI (NNRTI) for 1 year,at the baseline and 12,24 and 48 weeks after starting treatment,respectively.Results It was shown that the change of HIV-1 VL had a significantly negative correlation with CD3+CD4+ cell count,CD4+CD28+ and CD8+CD28+ cell counts and percentages,but a positive correlation with the cell count and percentage of CD8+CD38+,and the level of sCD27.The above parameters all showed more significant changes in the full responders,who showed good response to the anti-viral therapy,than in the partial responders with a rather bad response.Conelusion CD8+CD38+,CD4+CD28+ and CD8+CD28+ cell counts and their percentages,as well as the levels of sCD27 may be effective parameters in predicting AIDS progress and prognosis,and monitoring antiretroviral effects and immunologic response.

Key words: HIV-1, HIV infections, Antiretroviral therapy,highly active, Antigens,CD27, Antigens,CD38, Antigens,CD28